Johnson & Johnson, Distributors Reach $590M Opioid Settlement For Tribe Claims: Report
Johnson & Johnson (NYSE: JNJ) and the three U.S.
Ember Technologies, Cardinal Health Partner To Transform Pharmaceutical Cold Chain
Ember Technologies, Inc. (Ember®) and Cardinal Health (NYSE:CAH) today announced a partnership to offer the world's first self-refrigerated, cloud-based shipping box–the Ember Cube. Ember and
Barclays Maintains Overweight on Cardinal Health, Lowers Price Target to $63
Barclays analyst Steve Valiquette maintains Cardinal Health (NYSE:CAH) with a Overweight and lowers the price target from $65 to $63.
Cardinal Health Expects Inflationary Impact, Supply Chain Constraints To Hit Volumes In FY22
Cardinal Health Inc (NYSE: CAH) shares are trading lower after the company warned of additional inflationary effects and lower volumes from global supply chain constraints with lower-than-anticipated offset from pricing actions.
Teva Suffers Loss In New York’s Opioid Trial
A jury in Suffolk County State Supreme Court found Teva Pharmaceutical Industries Ltd (NYSE: TEVA) contributed to New York's opioid epidemic.
Clarity, Cardinal Health Enter Into Agreement For Targeted Copper Theranostics
Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, and Cardinal Health
McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters
A Washington state trial against McKesson Corporation (NYSE:MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE:ABC) for the U.S. opioid epidemic is slated to…
Barclays Maintains Overweight on Cardinal Health, Lowers Price Target to $65
Barclays analyst Steve Valiquette maintains Cardinal Health (NYSE:CAH) with a Overweight and lowers the price target from $68 to $65.
Cardinal Health Post Mixed Q1 Earnings; Reaffirms FY22 Adjusted EPS Outlook
Cardinal Health (NYSE:CAH) reported Q1 FY22 adjusted EPS of $1.29, down from $1.51 a year ago, missing the Street estimate…
Cardinal Health Q1 Adj. EPS $1.29 Misses $1.33 Estimate, Sales $44.00B Beat $41.93B Estimate
Cardinal Health (NYSE:CAH) reported quarterly earnings of $1.29 per share which missed the analyst consensus estimate of $1.33 by 3.01 percent. This is a 14.57 percent decrease over earnings of $1.51 per share from the